UnitedHealth, Amedisys Deal Deadline Extended
Hospice News
DECEMBER 27, 2024
UnitedHealth Group (NYSE: UNH) subsidiary Optum entered a new waiver agreement that has delayed the deadline to complete its $3.3 billion acquisition of Amedisys (Nasdaq: AMED). The agreement comes on the heels of an antitrust lawsuit that the U.S. Department of Justice (DOJ) filed last month to block the transaction due to concerns that it would reduce competition in the home health and hospice markets.
Let's personalize your content